NO20022245L - Onkolyttiske kombinasjoner for behandling av cancer - Google Patents

Onkolyttiske kombinasjoner for behandling av cancer

Info

Publication number
NO20022245L
NO20022245L NO20022245A NO20022245A NO20022245L NO 20022245 L NO20022245 L NO 20022245L NO 20022245 A NO20022245 A NO 20022245A NO 20022245 A NO20022245 A NO 20022245A NO 20022245 L NO20022245 L NO 20022245L
Authority
NO
Norway
Prior art keywords
cancer
treatment
oncolytic
combinations
oncolytic combinations
Prior art date
Application number
NO20022245A
Other languages
English (en)
Norwegian (no)
Other versions
NO20022245D0 (no
Inventor
Jerome Herbert Fleisch
Roger Stuart Benjamin
Jason Scott Sawyer
Beverly Ann Teicher
Douglas Wade Beight
Edward C R Smith
William Thomas Mcmillen
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO20022245D0 publication Critical patent/NO20022245D0/no
Publication of NO20022245L publication Critical patent/NO20022245L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
NO20022245A 1999-11-11 2002-05-10 Onkolyttiske kombinasjoner for behandling av cancer NO20022245L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16478699P 1999-11-11 1999-11-11
PCT/US2000/031039 WO2001034137A2 (en) 1999-11-11 2000-11-09 Oncolytic combinations for the treatment of cancer

Publications (2)

Publication Number Publication Date
NO20022245D0 NO20022245D0 (no) 2002-05-10
NO20022245L true NO20022245L (no) 2002-07-09

Family

ID=22596085

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022245A NO20022245L (no) 1999-11-11 2002-05-10 Onkolyttiske kombinasjoner for behandling av cancer

Country Status (22)

Country Link
EP (1) EP1231938A2 (hu)
JP (1) JP2003513916A (hu)
KR (1) KR20020069512A (hu)
CN (1) CN1390139A (hu)
AR (1) AR032432A1 (hu)
AU (1) AU778829B2 (hu)
BR (1) BR0015490A (hu)
CA (1) CA2391416A1 (hu)
CZ (1) CZ20021551A3 (hu)
EA (1) EA200200545A1 (hu)
HK (1) HK1050132A1 (hu)
HU (1) HUP0204449A3 (hu)
IL (1) IL148579A0 (hu)
MX (1) MXPA02004733A (hu)
NO (1) NO20022245L (hu)
NZ (1) NZ517667A (hu)
PE (1) PE20010701A1 (hu)
PL (1) PL355172A1 (hu)
SK (1) SK6492002A3 (hu)
TR (1) TR200201245T2 (hu)
WO (1) WO2001034137A2 (hu)
ZA (1) ZA200202822B (hu)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001034198A2 (en) * 1999-11-11 2001-05-17 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
WO2001034197A2 (en) * 1999-11-11 2001-05-17 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
US6797723B1 (en) 1999-11-11 2004-09-28 Eli Lilly And Company Heterocycle substituted diphenyl leukotriene antagonists
JP2001247459A (ja) 2000-03-03 2001-09-11 Oakland Uniservices Ltd 癌の組み合わせ療法
CA2408622A1 (en) * 2000-05-09 2001-11-15 Creighton University Methods for inhibiting proliferation and inducing apoptosis in cancer cells
JP2004505047A (ja) 2000-07-28 2004-02-19 キャンサー・リサーチ・テクノロジー・リミテッド 複合治療による癌治療
GB0121285D0 (en) 2001-09-03 2001-10-24 Cancer Res Ventures Ltd Anti-cancer combinations
GB2386836B (en) 2002-03-22 2006-07-26 Cancer Res Ventures Ltd Anti-cancer combinations
GB2394658A (en) 2002-11-01 2004-05-05 Cancer Rec Tech Ltd Oral anti-cancer composition
WO2005105736A1 (en) 2004-05-05 2005-11-10 Novo Nordisk A/S Novel compounds, their preparation and use
ES2352085T3 (es) 2004-05-05 2011-02-15 High Point Pharmaceuticals, Llc Nuevos compuestos, su preparación y uso.
CN1302782C (zh) * 2005-01-17 2007-03-07 北京京卫燕康药物研究所有限公司 盐酸吉西他滨溶液型注射剂
ATE529404T1 (de) 2005-06-30 2011-11-15 High Point Pharmaceuticals Llc Phenoxyessigsäuren als ppar-delta-aktivatoren
EP1979311B1 (en) 2005-12-22 2012-06-13 High Point Pharmaceuticals, LLC Phenoxy acetic acids as ppar delta activators
CA2645719A1 (en) 2006-03-09 2007-09-13 High Point Pharmaceuticals, Llc Compounds that modulate ppar activity, their preparation and use
AU2007307597A1 (en) 2006-10-12 2008-04-17 Institute Of Medicinal Molecular Design. Inc. Carboxylic acid derivatives
US8633245B2 (en) 2008-04-11 2014-01-21 Institute Of Medicinal Molecular Design, Inc. PAI-1 inhibitor
WO2014060381A1 (de) 2012-10-18 2014-04-24 Bayer Cropscience Ag Heterocyclische verbindungen als schädlingsbekämpfungsmittel
EP2914587A1 (de) 2012-10-31 2015-09-09 Bayer CropScience AG Neue heterocylische verbindungen als schädlingsbekämpfungsmittel
CN103319466B (zh) * 2013-07-04 2016-03-16 郑州大学 含香豆素母核的1,2,3-三唑-氨基二硫代甲酸酯化合物、制备方法及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6034256A (en) * 1997-04-21 2000-03-07 G.D. Searle & Co. Substituted benzopyran derivatives for the treatment of inflammation

Also Published As

Publication number Publication date
CN1390139A (zh) 2003-01-08
PL355172A1 (en) 2004-04-05
BR0015490A (pt) 2002-07-09
CZ20021551A3 (cs) 2003-02-12
NO20022245D0 (no) 2002-05-10
SK6492002A3 (en) 2003-09-11
ZA200202822B (en) 2003-09-23
HUP0204449A2 (hu) 2003-04-28
PE20010701A1 (es) 2001-07-07
TR200201245T2 (tr) 2004-08-23
AU1599001A (en) 2001-06-06
KR20020069512A (ko) 2002-09-04
AR032432A1 (es) 2003-11-12
WO2001034137A2 (en) 2001-05-17
EP1231938A2 (en) 2002-08-21
WO2001034137A3 (en) 2002-02-14
HUP0204449A3 (en) 2006-02-28
IL148579A0 (en) 2002-09-12
CA2391416A1 (en) 2001-05-17
MXPA02004733A (es) 2002-08-30
JP2003513916A (ja) 2003-04-15
AU778829B2 (en) 2004-12-23
HK1050132A1 (zh) 2003-06-13
NZ517667A (en) 2004-05-28
EA200200545A1 (ru) 2002-12-26

Similar Documents

Publication Publication Date Title
CY2016021I2 (el) Στελεχη ιων για την ογκολυτικη θεραπεια του καρκινου
NO20013369D0 (no) Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon
NO20025792L (no) Kinazolinderivater for behandling av tumorer
NO20021474D0 (no) Forbindelser for behandling av ischemi
NO20022245D0 (no) Onkolyttiske kombinasjoner for behandling av cancer
NO991700D0 (no) Benzimidazol-2-karbamater for behandling av virusinfeksjoner og cancer
NO20005864D0 (no) Quinasoler til behandling av hjernesvulst
FI20000863A (fi) Uusi hoitomenetelmä
DK1176964T3 (da) Brug af ET743 til behandling af cancer
NO20020358D0 (no) Anvendelse av etodolac for behandling av kreft
DE60023454D1 (de) Lagenmaterialen mit tensid-modifizierten chelatbildern behandelt
AU6062900A (en) Substituted indole compounds and their use for the treatment of cancer
AU1916601A (en) Oncolytic combinations for the treatment of cancer
NO20014725L (no) Forbedret kreftbehandling med temozolomid
AU1916501A (en) Oncolytic combinations for the treatment of cancer
NO20013596D0 (no) Slambehandling
AU1595001A (en) Oncolytic combinations for the treatment of cancer
AU1917101A (en) Oncolytic combinations for the treatment of cancer
PT1043025E (pt) Tratamento de carcinoma da celula renal
AU1595101A (en) Oncolytic combinations for the treatment of cancer
NO20014228L (no) Radioaktiv cisplatin i behandling av cancer
NO20014845D0 (no) Anvendelse av arylalkanoylpyridaziner
NO20014477L (no) Behandling av osteoartritis
AU1592901A (en) Oncolytic combinations for the treatment of cancer
SE9903421D0 (sv) Behandlingsförfarande

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application